Annals of Oncology

Obituary:

John F. Smyth

Professor Michel Clavel
Ann Oncol 4: 341.
[PDF] [Request Permissions]

In this issue:

In this issue
Ann Oncol 4: 342.
[PDF] [Request Permissions]

Contents of the next issue:

Contents of the next issue
Ann Oncol 4: 342.
[PDF] [Request Permissions]

News:

Call for the salvage of a cooperative oncology project
Ann Oncol 4: 343.
[PDF] [Request Permissions]

Breast cancer: More clarity or more confusion?
Ann Oncol 4: 343-344.
[PDF] [Request Permissions]

Euthanasia: More confusion than ever in The Netherlands
Ann Oncol 4: 344.
[PDF] [Request Permissions]

Battle over PCR fees
Ann Oncol 4: 344-345.
[PDF] [Request Permissions]

U.K. government policy change concerning tobacco ads?
Ann Oncol 4: 345.
[PDF] [Request Permissions]

Farmitalia bought by Kabi Pharmacia
Ann Oncol 4: 345.
[PDF] [Request Permissions]

Awards, appointments
Ann Oncol 4: 345.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 4: 345-346.
[PDF] [Request Permissions]

Editorial:

Michael J. Keating

Immunosuppression with purine analogues — the flip side of the gold coin
Ann Oncol 4: 347-348.
[PDF] [Request Permissions]

Jan P. Neijt

The challenge of dose-intensity in ovarian cancer
Ann Oncol 4: 349-350.
[PDF] [Request Permissions]

Special articles:

H. M. Pinedo

Dose effect relationship in breast cancer
Ann Oncol 4: 351-357.
[PDF] [Request Permissions]

Review:

G. Bonadonna, L. Gianni, A. Santoro, V. Bonfante, P. Bidoli, P. Casali, R. Demicheli, and P. Valagussa

Drugs ten years later: Epirubicin
Ann Oncol 4: 359-369.
[PDF] [Request Permissions]

Original articles:

L. Bergmann, K. Fenchel, B. Jahn, P. S. Mitrou, and D. Hoelzer

Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemia
Ann Oncol 4: 371-375.
[Abstract] [PDF] [Request Permissions]

D. Murphy, D. Crowther, J. Renninson, J. Prendiville, M. Ranson, M. Lind, U. Patel, M. Dougal, C. H. Buckley, and V. R. Tindall

A randomised dose intensity study in ovarian carcinoma comparing chemotherapy given at four week intervals for six cycles with half dose chemotherapy given for twelve cycles
Ann Oncol 4: 377-383.
[Abstract] [PDF] [Request Permissions]

A. M. Oza, T. S. Ganesan, M. Leahy, W. Gregory, J. Lim, L. Dadiotis, V. Barbounis, A. E. Jones, J. Amess, A. G. Stansfeld, A. Z. S. Rohatiner, P. F. M. Wrigley, and T. A. Lister

Patterns of survival in patients with Hodgkin's disease: Long follow up in a single centre
Ann Oncol 4: 385-392.
[Abstract] [PDF] [Request Permissions]

A. Johnson, E. Cavallin-Ståhl, and H. Anderson

Blood lymphocyte clonal excess in advanced non-Hodgkin's lymphoma. Relation to clinical data and prognosis
Ann Oncol 4: 393-398.
[Abstract] [PDF] [Request Permissions]

U. Müller and R. A. Stahel

Gonadal function after MACOP-B or VACOP-B with or without dose intensification and ABMT in young patients with aggressive non-Hodgkin's lymphoma
Ann Oncol 4: 399-402.
[Abstract] [PDF] [Request Permissions]

C. N. Sternberg, P. H. M. de Mulder, A. T. van Oosterom, S. D. Fossa, D. Giannarelli, and J. R. Soedirman

Escalated M-VAC chemotherapy and recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) in patients with advanced urothelial tract tumors
Ann Oncol 4: 403-407.
[Abstract] [PDF] [Request Permissions]

H. M. Earl, J. Pringle, H. Kemp, L. Morittu, D. Miles, and R. Souhami

Chemotherapy of malignant fibrous histiocytoma of bone
Ann Oncol 4: 409-415.
[Abstract] [PDF] [Request Permissions]

Book reviews:

F. Cavalli

Book review
Ann Oncol 4: 415.
[PDF] [Request Permissions]

Pinuccia Valagussa

Book review
Ann Oncol 4: 425.
[PDF] [Request Permissions]

A. Mantovani

Book review
Ann Oncol 4: 431.
[PDF] [Request Permissions]

Franco Muggia

Book Review
Ann Oncol 4: 436.
[PDF] [Request Permissions]

Clinical case:

J. A. Radford, G. R. Morgenstern, and D. Crowther

The management of Hodgkin's disease
Ann Oncol 4: 417-421.
[PDF] [Request Permissions]

Short report:

P. Alberto

Phase II study of an oral combination of doxifluridine, prednimustine and idarubicin (FUPRIDA) for first line treatment of advanced breast cancer
Ann Oncol 4: 423-425.
[Abstract] [PDF] [Request Permissions]

E. J. M. Roelofs, D. J. Th. Wagener, Th. Conroy, J. Wils, J. Th. Burghouts, M. Fickers, A. de Graeff, F. Lalisang, and B. Paillot

Phase II study of sequential high-dose methotrexate (MTX) and 5-fluorouracil (F) alternated with epirubicin (E) and cisplatin (P) [FEMTX-P] in advanced gastric cancer
Ann Oncol 4: 426-428.
[Abstract] [PDF] [Request Permissions]

A. Berruti, P. Borasio, A. Roncari, G. Gorzegno, C. Mossetti, and L. Dogliotti

Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide (ADOC) in invasive thymomas: Results in six patients
Ann Oncol 4: 429-431.
[Abstract] [PDF] [Request Permissions]

Letters:

D. Bissett and S.B. Kaye

Myocardial infarction after chemotherapy for testicular teratoma
Ann Oncol 4: 432.
[PDF] [Request Permissions]

J. I. Mayordomo and F. Rivera

Severe hypocalcaemia after treatment with oral clodronate and aminoglycoside
Ann Oncol 4: 432-433.
[PDF] [Request Permissions]

J. L. Mansi, T. R. J. Evans, A. Smith, C. Oakley, R. Wastnage, and A. Dalgleish

Should we be using 5-HT₃ antagonists as first line antiemetic therapy in cisplatin-based chemotherapy?
Ann Oncol 4: 433-434.
[PDF] [Request Permissions]

Rudolf A. Joss

Commentary on ‘Should we be using 5-HT₃ antagonists as first line antiemetic therapy in cisplatin-based chemotherapy?’
Ann Oncol 4: 434-435.
[PDF] [Request Permissions]

Instructions to Authors:

Instructions to Authors
Ann Oncol 4: 437-438.
[PDF] [Request Permissions]

Advertisements in this issue:

Kluwer Academic Publishers Group
Ann Oncol 4: 439.
[PDF] [Request Permissions]

Clasified advertisements from ESMO–members and meeting announcements
Ann Oncol 4: 440.
[PDF] [Request Permissions]

Fifth Pezcoller Symposium Announcements
Ann Oncol 4: 441.
[PDF] [Request Permissions]

ECC * ESMO postgraduate course
Ann Oncol 4: 442.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.